Tripelennamine

CHEMBL1241 Phase 4 Zugelassen Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

255.4 g/mol

LogP

3.3

Phase

4

Tripelennamine is a first-generation H1 antihistamine that competitively blocks histamine at H1 receptors, reducing allergic symptoms such as itching, urticaria, rhinorrhea, and conjunctivitis. It has significant sedative and anticholinergic properties due to central nervous system penetration. It was used for allergic conditions and as a component in some illicit drug preparations due to its CNS effects.

Molekularmasse

255,3600 g/mol

LogP

3,30

TPSA

19,40 Å²

Lipinski-Regel der Fünf

Bestanden

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure

Embed this structure

SMILES

CN(C)CCN(Cc1ccccc1)c1ccccn1

InChI

InChI=1S/C16H21N3/c1-18(2)12-13-19(16-10-6-7-11-17-16)14-15-8-4-3-5-9-15/h3-11H,12-14H2,1-2H3

Molecular Formula

C16H21N3

HBD / HBA

- / 3

Rotierbare Bindungen

6

Schwere Atome

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

Tripelennamine is a first-generation H1 antihistamine that competitively blocks histamine at H1 receptors, reducing allergic symptoms such as itching, urticaria, rhinorrhea, and conjunctivitis. It has significant sedative and anticholinergic properties due to central nervous system penetration. It was used for allergic conditions and as a component in some illicit drug preparations due to its CNS effects.

Yes, Tripelennamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1241. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5587. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Suchen Sie patientenfreundliche Informationen?

Tripelennamine auf PillFYI

Struktur

Schnelldaten

Formel: C16H21N3
Synonyme: 5

Externe Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.